Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -14.19% is 66% above its 5-year average of -41.26%, near the high end of its 5-year range (-76.21%–-10.77%).
As of the fiscal period ended Wednesday, December 31, 2025. 67.37% above its 12-month average of -43.49%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
-14.19%
RETURN ON ASSETS (ROA) AVG TTM
-43.49%
RETURN ON ASSETS (ROA) AVG 3Y
-42.71%
RETURN ON ASSETS (ROA) AVG 5Y
-41.26%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+67.37%
CURRENT VS 3Y AVG
+66.78%
CURRENT VS 5Y AVG
+65.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.93%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-387.83%
vs the sector median at left
Tempus AI, Inc.
Market Cap
$7.51B
Return on Assets (ROA)
-14.19%
TTM Avg
-43.49%
3Y Avg
-42.71%
5Y Avg
-41.26%
Market Cap
$7.35B
Return on Assets (ROA)
-0.42%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$6.75B
Return on Assets (ROA)
-0.58%
TTM Avg
11.88%
3Y Avg
0.12%
5Y Avg
-6.73%
Market Cap
$8.55B
Return on Assets (ROA)
1.72%
TTM Avg
-6.26%
3Y Avg
-11.14%
5Y Avg
1.46%
Market Cap
$9.64B
Return on Assets (ROA)
3.49%
TTM Avg
3.68%
3Y Avg
4.39%
5Y Avg
5.01%
Market Cap
$9.97B
Return on Assets (ROA)
9.70%
TTM Avg
8.61%
3Y Avg
6.84%
5Y Avg
6.99%
Market Cap
$10.37B
Return on Assets (ROA)
-9.07%
TTM Avg
-6.92%
3Y Avg
-1.48%
5Y Avg
0.07%
Market Cap
$10.41B
Return on Assets (ROA)
-0.04%
TTM Avg
5.29%
3Y Avg
6.08%
5Y Avg
6.13%
Market Cap
$10.80B
Return on Assets (ROA)
-2.39%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tempus AI, Inc. (TEM) | $7.51B | -14.19% | -43.49% | -42.71% | -41.26% |
| Oscar Health, Inc. (OSCR)vs › | $7.35B | -0.42% | -3.24% | -6.85% | -10.42% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.75B | -0.58% | 11.88% | 0.12% | -6.73% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.55B | 1.72% | -6.26% | -11.14% | 1.46% |
| Henry Schein, Inc. (HSIC)vs › | $9.64B | 3.49% | 3.68% | 4.39% | 5.01% |
| Universal Health Services, Inc. (UHS)vs › | $9.97B | 9.70% | 8.61% | 6.84% | 6.99% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -9.07% | -6.92% | -1.48% | 0.07% |
| Molina Healthcare, Inc. (MOH)vs › | $10.41B | -0.04% | 5.29% | 6.08% | 6.13% |
| Charles River Laboratories International, Inc. (CRL)vs › | $10.80B | -2.39% | -0.94% | 2.58% | 3.75% |
| Bio-Techne Corporation (TECH)vs › | $11.21B | 4.30% | 4.54% | 7.94% | 8.21% |
ROA
-14.2%
ROE
-72.7%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -10.77% |
| 2024-12-31 | -76.21% |
| 2023-12-31 | -37.96% |
| 2022-12-31 | -45.90% |
| 2021-12-31 | -48.78% |
| 2020-12-31 | -27.91% |
| 2019-12-31 | -31.05% |
